BLOG

NK Cell Therapy in Osaka: Planning Your Schedule and Travel

7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you are considering NK cell therapy in Japan from overseas, one of the first practical questions is logistics. How many visits are involved, how long might you need to stay in Osaka, and how does the timing fit around the treatment you are already receiving at home? This article explains the general flow of NK cell therapy at Grand Green Osaka Umekita Clinic and the questions worth raising before you book travel.

Please note that this is general information, not medical advice. The exact schedule, number of infusions and total time away from home are decided by a doctor after a consultation, and they can differ from one person to the next.

Short answer: plan around a doctor-confirmed schedule

NK cell therapy is not a single walk-in procedure. Your own NK cells are collected from a blood draw, activated and expanded at a specialized cell processing facility, and later returned to your body by intravenous infusion. Because the cells have to be prepared between the blood draw and the infusion, the timeline includes waiting periods that need to be built into your plans.

For that reason, it is sensible to avoid fixing flights and hotels until a doctor has explained the proposed schedule for your situation. The clinic offers consultations, and an information page for international patients is available in several languages, so you can start by understanding the process before deciding anything.

What the treatment flow generally looks like

According to the clinic’s treatment page, the therapy is built around a few simple elements: a standard blood draw, cell activation and expansion outside the body, and an intravenous infusion. It does not require hospitalization, and daily life can usually continue around visits, although individual circumstances vary.

  • A consultation, in which a doctor reviews your medical history, current cancer treatment and goals.
  • A blood draw to obtain the NK cells that will be processed.
  • Activation and expansion of the cells at a licensed facility, which takes time.
  • An intravenous infusion to return the prepared cells to your body.
  • Follow-up and a discussion of whether further infusions are appropriate.

Whether the treatment involves a single infusion or several, and how far apart they are, should be explained by your doctor. Do not assume that a schedule described for another patient, or on another website, will apply to you.

Questions to ask about timing and travel

International patients often need to coordinate work, family and flights, so it helps to bring specific questions to the first consultation. The following list may be a useful starting point.

  • How many separate visits to the clinic are proposed, and which ones must be in person?
  • How long does the cell preparation take, and what happens if it takes longer than expected?
  • Could a postponed infusion affect the rest of the plan?
  • Are there reasons my infusion might need to be delayed, such as a fever or a change in my other treatment?
  • What should I do if I feel unwell after returning home?
  • Can follow-up be done remotely, or will I need to return to Osaka?

Asking these questions in advance makes it easier to compare the plan with your other commitments and helps avoid surprises. If you need an interpreter or materials in your own language, it is reasonable to ask what support is available.

Fitting NK cell therapy around standard cancer treatment

The clinic describes NK cell therapy as an option that can be considered alongside surgery, chemotherapy or radiation therapy, and it states that it can coordinate with the medical institution providing standard treatment. Standard treatment remains the foundation of cancer care, and NK cell therapy is not a replacement for it.

If you are in the middle of chemotherapy or radiation, your oncologist at home should know about any plan to receive additional treatment abroad. Timing matters: your blood counts, your treatment cycles and your overall condition may influence when a blood draw or an infusion is appropriate. Bringing recent test results, a treatment summary and your oncologist’s contact details can help the doctor in Osaka give a more informed view.

It is also worth asking your own oncologist what they think about the timing, and whether they would like to receive a report afterward. A shared understanding between both doctors is usually more useful than any single travel plan.

Regulation, fees and what remains uncertain

In Japan, NK cell therapy is provided as a self-pay (non-insured) treatment, meaning it is not covered by national health insurance. It is delivered under the Act on the Safety of Regenerative Medicine, which requires a treatment plan to be submitted to and accepted by the authorities. That framework addresses how cells are handled and how treatment is provided, but it does not mean that benefits are certain for any individual patient.

Please also keep in mind that responses to immune cell therapy differ from person to person, and the evidence for this approach is still developing. Temporary reactions such as fever or fatigue have been described, and a doctor should explain the possible risks and side effects before you decide. Costs depend on the plan, so ask for a written explanation of fees, including anything that may be charged if the schedule changes.

How to take the next step

A practical way to begin is to read the NK cell therapy page and the information for international patients on the clinic’s website, then prepare a short list of questions about timing, fees, risks and coordination with your home doctor. From there, you can book a consultation with the Osaka clinic in Umeda to discuss whether the therapy is suitable and what a realistic schedule might look like.

The decision to travel for treatment is a personal one. Taking time to understand the process, speaking with both your home oncologist and the doctor in Osaka, and confirming the details in writing can help you make a choice that fits your medical situation and your life.

Learn more about NK Cell Therapy

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact